Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ertl

Showing results (21-30 of 262) with videos related to

Pageof 27
Sort By:
Basic Research in Cardiology|September 1, 1980
A model for the investigation of regional coronary vascular resistances. Physical features as compared with experimental resultsF Simm, G Ertl
European Heart Journal|April 1, 1990
Coronary arteriolar vasoconstriction in myocardial ischaemia. Vasopressin, renin-angiotensin system and ANFG Ertl, B Bauer
Deutsche Medizinische Wochenschrift (1946)|April 7, 1989
[Angiotensin-converting enzyme inhibitors and ischemic heart disease]G Ertl, K Kochsiek
Der Internist|April 11, 2022
[Specialist training in internal medicine-The sixth special edition is here! : Case-related learning based on the new model specialty training regulations]G Ertl, A Arlt
Journal of Cardiovascular Risk|August 27, 1999
Left ventricular remodelling during treatment with beta-blockersG Ertl, K Hu
Circulation|May 1, 1993
Development, early treatment, and prevention of heart failure. IntroductionG Ertl, K Kochsiek
Herz|June 29, 2018
[Heart failure networks and centers : What does everyday life look like?]G Güder, G Ertl
Deutsche Medizinische Wochenschrift (1946)|March 31, 2011
[Internal medicine is more than the sum of its subspecialties]G Ertl, H Lehnert
Basic Research in Cardiology|January 1, 1996
Angiotensin II type 1 receptor induced signal-transduction pathways as new targets for pharmacological treatment of the renin-angiotensin systemW Schorb, G Ertl
Lancet (London, England)|October 15, 1994
ACE inhibition after myocardial infarction: can megatrials provide answers?G Ertl, B Jugdutt
Pageof 27

Showing results (21-30 of 262) with videos related to

Sort By:
Pageof 27
Basic Research in Cardiology|September 1, 1980
A model for the investigation of regional coronary vascular resistances. Physical features as compared with experimental resultsF Simm, G Ertl
European Heart Journal|April 1, 1990
Coronary arteriolar vasoconstriction in myocardial ischaemia. Vasopressin, renin-angiotensin system and ANFG Ertl, B Bauer
Deutsche Medizinische Wochenschrift (1946)|April 7, 1989
[Angiotensin-converting enzyme inhibitors and ischemic heart disease]G Ertl, K Kochsiek
Der Internist|April 11, 2022
[Specialist training in internal medicine-The sixth special edition is here! : Case-related learning based on the new model specialty training regulations]G Ertl, A Arlt
Journal of Cardiovascular Risk|August 27, 1999
Left ventricular remodelling during treatment with beta-blockersG Ertl, K Hu
Circulation|May 1, 1993
Development, early treatment, and prevention of heart failure. IntroductionG Ertl, K Kochsiek
Herz|June 29, 2018
[Heart failure networks and centers : What does everyday life look like?]G Güder, G Ertl
Deutsche Medizinische Wochenschrift (1946)|March 31, 2011
[Internal medicine is more than the sum of its subspecialties]G Ertl, H Lehnert
Basic Research in Cardiology|January 1, 1996
Angiotensin II type 1 receptor induced signal-transduction pathways as new targets for pharmacological treatment of the renin-angiotensin systemW Schorb, G Ertl
Lancet (London, England)|October 15, 1994
ACE inhibition after myocardial infarction: can megatrials provide answers?G Ertl, B Jugdutt
Pageof 27